Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Perchlorate refers to the anion ClO4− and its salts (such as potassium perchlorate and sodium perchlorate), which have been used pharmaceutically to treat hyperthyroidism. Perchlorates act as competitive inhibitors of the sodium-iodide symporter (NIS) in the thyroid gland, blocking iodide uptake and thereby reducing thyroid hormone synthesis. This mechanism has made them useful for treating conditions like Graves' disease and other forms of thyrotoxicosis. However, due to risks such as aplastic anemia and nephrotic syndrome at higher or prolonged doses, their use has declined in favor of safer alternatives. Perchlorates are rapidly absorbed from the gastrointestinal tract after ingestion and excreted unchanged in urine with a half-life of 6–8 hours[1][6][8]. They are also used industrially (e.g., explosives, rocket propellants) and can be environmental contaminants affecting thyroid function[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on perchlorate.